Bayer makes 2 consumer health appointments
WHIPPANY, N.J. — Bayer’s consumer health business has two new executives. The company this week named Brenda Raphael SVP and general manager of its therapeutics business unit within the North American consumer health division, and named Jennifer Brendel VP and head of U.S. consumer health communications
Raphael joins the company from Pfizer, where she was GM U.S. brands in pharmacy at the company’s New York City headquarters. And her experience encompasses consumer goods as well, having previously held senior leadership positions at Coca-Cola and Procter & Gamble. In her new role
“Brenda has more than 20 years of experience in leading successful billion-dollar, consumer-focused brands,” Bayer North America Consumer Health’s consumer health division president Natalie Bartner said. “Her strengths in understanding customers, marketing and innovation will lead the Therapeutics Business Unit to continue developing self-care solutions that help people live healthier lives.”
As the new VP and head of U.S. consumer health communications, Brendel brings to the position her recent 15-month stint at the helm of Bayer’s pharmaceutical product communications, developing internal and external communications strategies for such consumer health brands as Aleve, Coppertone and aspirin. In her new role, Brendel joins Bayer’s U.S. communications, government relations and policy leadership team.
“I am excited to have Jen take on this new leadership role as we continue to raise Bayer's profile in the United States" Bayer SVP and head of communications, government relations and policy Raymond Kerins, Jr., said. “Jen is a tremendous communications professional. Her years of experience managing major consumer brands plus her knowledge of our company's strategy and values makes her perfectly suited to lead communications for the largest Consumer Health company in the United States, Bayer's largest and fastest growing market.”
Before joining Bayer, Brendel worked for nearly a decade in marketing and communications roles for Pfizer, most recently as global marketing lead for Celebrex.